Computerized Cognitive Exercise Training Treatment for Adults With Mul
Plasticity-based, Adaptive, Computerized Cognitive Remediation Treatment (PACR) for Adults With Multiple Sclerosis (MS)
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- PACR (Plasticity-based, Adaptive, Computerized Cognitive Remediation)
What it measured
Main measures
A composite derived from a standardized battery of neuropsychological tests
12weeks
Thinking and memory
Other measures (1)
A timed measure based on direct observation of functional performance
12 weeks
Who could take part
MS (type not specified) · 18 to 70
Show the full criteria
Inclusion criteria
* Ages 18-70 * Definite MS Diagnosis, any subtype [83] * Probable cognitive impairment as defined by a score ≤ 1 SD below the mean of normative data on the SDMT * Concurrent medications to be kept constant over three months (as possible) * No relapse or steroids in previous month * Reading score on WRAT-3 of 37 or greater * Visual, auditory and motor capacity to operate computer software, as judged by treating neurologist or study staff * Willing to sign Agreement to Borrow Laptop
Exclusion criteria
* History of mental retardation, pervasive developmental disorder or other neurological condition associated with cognitive impairment * Primary psychiatric disorder that would influence ability to participate * Other serious uncontrolled medical condition (e.g., cancer or acute myocardial infarction) * Alcohol or other substance use disorder * History of computer-based training manufactured by Posit Science * Learned English language after 12 years of age
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Cognitive impairment remains a major disability for individuals with multiple sclerosis (MS). The primary objective of this study is to evaluate the efficacy for treating MS-associated cognitive deficits using a unique computer-based plasticity-based and adaptive cognitive remediation treatment (PACR) compared to a computer-based control. This novel cognitive remediation approach has led to striking improvements in cognitive functioning in other disorders (schizophrenia, traumatic brain injury, aging, and dementia) but has never been applied to individuals with MS. The investigators will enroll 136 MS participants who will be randomized in a 2:1 pattern to complete either the treatment or control condition for 60 hours across a 12-week treatment period. Both the treatment and control conditions will be accessed remotely by the subjects from a study-provided laptop computer. Study outcomes will include program compliance, performance on study tasks and neuropsychological measures, quality of life and functional status. Given the success of this program with other disorders and strong preliminary data from our feasibility study, the investigators believe PACR is an exciting untapped opportunity to improve cognition in individuals with MS.
Papers
Loading reviews and guidelines…
History
Started
Sept 2013
Main results due
Sept 2015